Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.

about

Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy.

P2860

Q49923401-AFA3C96A-96E0-44BD-BFE4-53179C41E256

P2860

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.

Item

http://www.wikidata.org/entity/Q38849166

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Inhibition of monocarboxyate t ...... lymphoma and Burkitt lymphoma.

@en

type

Item

label

Inhibition of monocarboxyate t ...... lymphoma and Burkitt lymphoma.

@en

prefLabel

Inhibition of monocarboxyate t ...... lymphoma and Burkitt lymphoma.

@en

P1476

Inhibition of monocarboxyate t ...... lymphoma and Burkitt lymphoma.

@en

P2093

Anna Long

http://www.w3.org/2001/XMLSchema#string

Arti Sikka

http://www.w3.org/2001/XMLSchema#string

Despina Televantou

http://www.w3.org/2001/XMLSchema#string

Hector C Keun

http://www.w3.org/2001/XMLSchema#string

Helen Blair

http://www.w3.org/2001/XMLSchema#string

Huw Thomas

http://www.w3.org/2001/XMLSchema#string

Natalie Bell

http://www.w3.org/2001/XMLSchema#string

Nicole Phillips

http://www.w3.org/2001/XMLSchema#string

Richard A Noble

http://www.w3.org/2001/XMLSchema#string

Sirintra Nakjang

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression

On the Origin of Cancer Cells

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Aerobic glycolysis: meeting the metabolic requirements of cell proliferation

Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.

Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis.

The monocarboxylate transporter family--Structure and functional characterization.

P304

1247-1257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2016.163030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28385782

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

P932

5566036

http://www.w3.org/2001/XMLSchema#string

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.

about

P2860

P2860

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932